Cerevel Therapeutics Holdings Inc’s filing revealed that its Director COLES N ANTHONY unloaded Company’s shares for reported $2.05 million on Mar 04 ’24. In the deal valued at $41.01 per share,50,000 shares were sold. As a result of this transaction, COLES N ANTHONY now holds 15,638 shares worth roughly $0.66 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, COLES N ANTHONY sold 50,000 shares, generating $2,057,890 in total proceeds. Upon selling the shares at $41.16, the Director now owns 15,638 shares.
Before that, COLES N ANTHONY sold 2,506 shares. Cerevel Therapeutics Holdings Inc shares valued at $104,110 were divested by the Director at a price of $41.54 per share. As a result of the transaction, COLES N ANTHONY now holds 15,638 shares, worth roughly $0.66 million.
TD Cowen downgraded its Cerevel Therapeutics Holdings Inc [CERE] rating to a Market perform from a an Outperform in a research note published recently. Piper Sandler began covering CERE with “an Overweight” recommendation on September 28, 2023. BofA Securities revised its rating on August 03, 2023. It rated CERE as “a Neutral” which previously was an “a Buy”.
Price Performance Review of CERE
On Monday, Cerevel Therapeutics Holdings Inc [NASDAQ:CERE] saw its stock jump 0.50% to $42.40. Over the last five days, the stock has lost -0.38%. Nevertheless, the stocks have risen 80.96% over the past one year. While a 52-week high of $43.59 was reached on 02/15/24, a 52-week low of $19.59 was recorded on 02/22/24. SMA at 50 days reached $41.93, while 200 days put it at $31.77. A total of 1.56 million shares were traded, compared to the trading of 0.74 million shares in the previous session.
Levels Of Support And Resistance For CERE Stock
The 24-hour chart illustrates a support level at 42.25, which if violated will result in even more drops to 42.10. On the upside, there is a resistance level at 42.50. A further resistance level may holdings at 42.60. The Relative Strength Index (RSI) on the 14-day chart is 61.67, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.29, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 23.30%. Stochastics %K at 72.29% indicates the stock is a holding.
How much short interest is there in Cerevel Therapeutics Holdings Inc?
A steep rise in short interest was recorded in Cerevel Therapeutics Holdings Inc stocks on Feb 29, 2024, growing by 1.08 million shares to a total of 7.1 million shares. Yahoo Finance data shows the prior-month short interest on Jan 31, 2024 was 6.02 million shares. There was a rise of 15.21%, which implies that there is a positive sentiment for the stock. In spite of short shares comprising just 8.23% of the overall stock float, the days-to-cover ratio (short ratio) rose to 4.18.
